文献速递浆细胞疾病

多发性骨髓瘤中NK细胞CD56bright与CD56dim亚群细胞因子丢失及耗竭与生存受损相关

NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma.
PubMed 文献 · Blood Adv · 2022-01-01

该研究采用质谱流式技术检测新诊断多发性骨髓瘤(NDMM)患者NK细胞亚群表型与功能,发现NK细胞向CD56bright但功能障碍的细胞毒表型偏移并选择性丢失细胞因子产生,CD56dim亚群呈现耗竭特征(增殖受损、PD-1上调、TIM-3表达丢失),NK细胞活化标志物低表达与较差长期生存相关。

要点

  • NDMM患者NK细胞向CD56bright但功能障碍的细胞毒表型偏移,选择性丢失细胞因子产生。
  • CD56dim亚群呈现耗竭特征:增殖受损、PD-1上调、TIM-3表达丢失。
  • NK细胞活化标志物低表达与较差长期生存相关。

核心结论

  • NK细胞耗竭在骨髓瘤诊断时即已存在,可能促进恶性浆细胞免疫控制丧失。
  • 通过免疫导向疗法恢复NK细胞功能为恢复多发性骨髓瘤免疫控制提供了途径。

研究设计与样本

  • 采用质谱流式技术检测新诊断多发性骨髓瘤(NDMM)患者NK细胞亚群的表型与功能。

主要发现

  • NDMM中NK细胞向CD56bright但功能障碍的细胞毒表型偏移,并选择性丢失细胞因子产生。
  • CD56dim亚群呈现耗竭特征:增殖受损、PD-1上调、TIM-3表达丢失。
  • NK细胞活化标志物低表达与较差长期生存相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Natural killer (NK) cells are the key cells of the innate immune system that share many characteristics with T lymphocytes; their activation, however, is based on the integration of a range of activatory and inhibitory signals via receptors recognizing recurrent pathogen-associated molecular patterns. Two important populations of NK cells with differing functions are recognized: CD56bright and CD56dim. NK cells have the potential to recognize and kill malignant plasma cells, which offers therapeutic opportunities. We used mass cytometry to examine the phenotype and function of NK cell subsets from patients with newly diagnosed multiple myeloma (NDMM). We show that NK cells in NDMM are shifted toward a CD56bright but dysfunctional cytotoxic phenotype, which exhibits selective loss of cytokine production. The CD56dim subset has features of exhaustion with impaired proliferation, upregulation of programmed cell death protein 1, and loss of T-cell immunoglobulin and mucin domain 3 expression. Poor expression of NK cell activation markers is seen and is associated with inferior long-term survival. These results suggest that NK cell exhaustion is already present by the time of myeloma diagnosis and likely contributes to the loss of immunologic control of malignant plasma cells. Restoring NK cell function via immune-directed therapies offers a route to restoring immunologic control in multiple myeloma.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Seymour F, Cavenagh JD, Mathews J, et al. NK cells CD56bright and CD56dim subset cytokine loss and exhaustion is associated with impaired survival in myeloma. Blood Adv. 2022. PMID: 35834731. doi:10.1182/bloodadvances.2022007905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。